We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Shiatsu Adjuvant Therapy For Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00425399
Recruitment Status : Completed
First Posted : January 23, 2007
Last Update Posted : May 22, 2014
Information provided by:
Herzog Hospital

Brief Summary:

In the current study we will study the effect of adding shiatsu treatment to conventional therapy in work with hospitalized schizophrenic patients.

The hypotheses of this study are several:

  1. Shiatsu can improve the patients' symptoms
  2. Shiatsu can ameliorate neuromuscular side effects produced by standard anti-psychotic treatment
  3. Shiatsu can provide patients with tools to deal with the stresses of their illness

2. Methodology We propose an open pilot study in which a total of 20 patients of both sexes will be enrolled. These patients will be drawn from the inpatient psychiatric wards at Herzog Hospital.

Upon inclusion into the trial, all participants will receive shiatsu treatment, consisting of two individual weekly 40-minute shiatsu treatment sessions for four weeks. Provider and patient will be of the same gender. Standard pharmacotherapy will be provided as needed during the treatment period. Medication and dosage will not be changed. If necessary, benzodiazepines will be administered as required.

Outcome measures:

The following assessments will be included:

  1. Medication: Use of SOS benzodiazepines
  2. Clinical rating scales: PANSS, CGI, NOSIE, Hamilton Scales for depression and anxiety

1. Side effect scales: Simpson Angus Scale, AIMS scale, UKU scale 2. Neurophysiological testing: Prepulse inhibition (PPI). 3. Neurocognitive testing: This will be performed using the NIMH's Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery for Clinical Trials.

Condition or disease Intervention/treatment
Schizophrenia Procedure: Shiatsu

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Shiatsu Adjuvant Therapy for Hospitalized Psychiatric Patients: an Open Pilot Study
Study Start Date : January 2007
Study Completion Date : June 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia
U.S. FDA Resources

Intervention Details:
    Procedure: Shiatsu
    Shiatsu treatment provided in 40-minute sessions, twice a week for 4 weeks

Primary Outcome Measures :
  1. Brief Psychiatric Rating Scale (BPRS) [ Time Frame: 4 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. DSM-IV-R diagnosis of schizophrenia or schizoaffective disorder
  2. Ages 18 and over
  3. Clinical status stable, as reflected by at least one month of drug treatment without change of anti-psychotic drug or dosage.
  4. Ability to cooperate with 40-minute sessions

Exclusion Criteria:

  1. Active fracture or other orthopedic problem
  2. Skin condition that renders treatment unsafe or painful
  3. Active infection in skin or soft tissues, such as cellulitis
  4. Any acute illness or other medical condition (e.g. solid tissue malignancy) for which shiatsu may be contraindicated

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00425399

Herzog Hospital, Department of Psychiatry
Jerusalem, Israel, 91351
Sponsors and Collaborators
Herzog Hospital
Principal Investigator: Pesach Lichtenberg, M.D. Herzog Hospital

Responsible Party: Dr. Pesach Lichtenberg, Herzog Hospital
ClinicalTrials.gov Identifier: NCT00425399     History of Changes
Other Study ID Numbers: lichtenbergCTIL2
First Posted: January 23, 2007    Key Record Dates
Last Update Posted: May 22, 2014
Last Verified: February 2009

Keywords provided by Herzog Hospital:

Additional relevant MeSH terms:
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders